PSMA PET/CT to evaluate response to SBRT for prostate cancer bone metastases

医学 前列腺癌 骨转移 前列腺 放射科 病历 转移 回顾性队列研究 核医学 癌症 内科学
作者
I. Sadetskii,Yael Eshet,Orit Kaidar‐Person,Uri Amit,Liran Domachevsky,Tima Davidson,Ilana Weiss,Maoz Ben-Ayun,Zvi Symon
出处
期刊:Reports of Practical Oncology & Radiotherapy [Elsevier BV]
卷期号:26 (4): 528-534 被引量:12
标识
DOI:10.5603/rpor.a2021.0071
摘要

Background: In the current study we evaluated 68Ga PSMA PET/ CT to measure local control of bone metastasis in oligometastatic prostate cancer patients treated with SBRT. Materials and methods: After the institutional review board approval, a retrospective review of medical records of consecutive prostate cancer patients treated between 2014 and 2018 was conducted. Only medical records of patients that were treated with SBRT for bone metastasis and had pre-and post-SBRT 68Ga PSMA PET/CT scans were included in our study. Data extracted from the medical files included patient-related (age), disease-related (Gleason score, site of metastasis), and treatment-related factors and outcomes. Results: During the study period, a total of 12 patients (15 lesions) were included, with a median age of 73 years. The median follow-up was 26.5 months (range 13–45 months). Median time of 68Ga PSMA PET/ CT follow up was 17.0 months (range 3–39 months). The median pre-treatment PSA was 2 ng/mL (range 0.56–44 ng/mL) vs. post treatment PSA nadir of 0.01 ng/mL (0.01–4.32) with a median time to nadir of 7 months (range, 2–12). Local control was 93% during the follow up period and there was correlation with PSMA avidity on PET. None patients developed recurrences in the treated bone. None of the patients had grade 3 or more toxicities during follow-up. Conclusions: SBRT is a highly effective and safe method for treatment of prostate cancer bone metastases. More studies are required to determine if SBRT provides greater clinical benefit than standard fractionation for oligometastatic prostate cancer patients. 68Ga PSMA PET/CT should be further investigated for delineation and follow-up.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
明乎坦涂完成签到,获得积分10
刚刚
酷波er的应助被corleeang采纳,获得10
1秒前
文静曼安发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
阎罗恶煞发布了新的文献求助10
2秒前
曾经的安珊完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
kimbrough发布了新的文献求助10
3秒前
Xiong完成签到,获得积分10
3秒前
zjz1发布了新的文献求助10
3秒前
3秒前
3秒前
0001发布了新的文献求助10
3秒前
ltt发布了新的文献求助10
3秒前
yyy完成签到,获得积分10
4秒前
4秒前
张建秀完成签到,获得积分10
6秒前
6秒前
彭静琳发布了新的文献求助10
6秒前
6秒前
wway完成签到 ,获得积分10
7秒前
阿业发布了新的文献求助10
7秒前
DW的应助被自信诗桃采纳,获得10
7秒前
红糖馒头发布了新的文献求助10
8秒前
呆呆发布了新的文献求助10
8秒前
33完成签到,获得积分10
8秒前
所所的应助被I_CAN采纳,获得10
8秒前
爱听歌的火龙果完成签到,获得积分10
8秒前
万能图书馆的应助被Donghaol采纳,获得10
8秒前
8秒前
充电宝的应助被曾宪煌采纳,获得10
9秒前
无花果的应助被corleeang采纳,获得10
9秒前
SciGPT的应助被Rosetta采纳,获得10
9秒前
9秒前
清辉影发布了新的文献求助10
9秒前
文静曼安完成签到,获得积分20
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124